NATURE’S SUNSHINE PRODUCTS, INC. Number of Operating Segments
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Number of Operating Segments of 4 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. number of operating segments for the quarter ending 2013-03-31 was 2.00 item.
- NATURE’S SUNSHINE PRODUCTS, INC. number of operating segments for fiscal 2012 was 2.00 item.
item
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 12 month |
|---|---|---|
| 2013-03-31 | 2.00 item 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 2.00 item 10-K · filed 2013-03-07 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month |
|---|---|---|---|
| 2026-06-30 | 4.00 segment 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 4.00 segment 10-Q · filed 2026-05-07 | ||
| 2025-09-30 | 4.00 segment 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 4.00 segment 10-Q · filed 2025-07-31 | ||
| 2019-03-31 | 4.00 segment 10-Q · filed 2019-05-09 | ||
| 2018-03-31 | 4.00 segment 10-Q · filed 2018-05-10 | ||
| 2017-09-30 | 3.00 segment 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 3.00 segment 10-Q · filed 2017-08-09 | ||
| 2017-03-31 | 3.00 segment 10-Q · filed 2017-05-10 | ||
| 2016-09-30 | 3.00 segment 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | 3.00 segment 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 3.00 segment 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |